Key Highlights

  • ClearOne (NASDAQ:CLRO) fell 7.75% pre-market to a listed USD 4.13 on 7,874 shares, with a market capitalization of USD 11 million and an RSI of 45.8 labeled Down.
  • On October 8 ClearOne received a Nasdaq staff determination to delist its shares because it did not meet the USD 2.5 million minimum stockholders' equity requirement.
  • The company plans to request a hearing by October 15 and present a plan to regain compliance, with no assurance that Nasdaq will grant it.
  • A below-market unit offering of up to USD 15 million and the Cortigent merger agreement signal further dilution, and the stock fell 7.75% on 7,874 shares.

What Is Moving the Stock

ClearOne disclosed on October 8, 2026 that Nasdaq staff determined to delist its securities after the company failed to complete the remedial actions in a compliance plan submitted on May 22 for the stockholders' equity requirement. The problem began with an April 7 notice that the company met none of the alternative continued listing standards, and Nasdaq granted an exception until October 4 that has now lapsed. The company intends to request a hearing before a Nasdaq Hearings Panel by October 15, and a hearing request typically stays suspension while the panel decides.

The Data Behind the Move

On August 25, majority holders approved the issuance of units of one share and one warrant for gross proceeds of up to USD 15 million at a price below the Nasdaq minimum price, which may exceed 20% of the shares outstanding. The company agreed on July 1 to merge with Cortigent, cancelled 437,500 warrants and in March sold 437,500 shares at USD 4.00 plus warrants for USD 1.75 million. The market value is about USD 11 million, so the planned USD 15 million unit raise would exceed the entire market value, simple arithmetic. If the listed price is the pre-market quote, simple arithmetic puts the prior close near USD 4.48; if it is the last close, the implied pre-market price is near USD 3.81, so check a live quote. Pre-market traded value is only about USD 0.03 million, a tiny slice of the company's size, so few dollars set the price. Volume of 7,874 shares is thin, under 10,000 shares, and the screener tag reads Listing notice, which classifies the catalyst and does not set direction.

Risks and What to Watch

Delisting, heavy dilution from a raise larger than the market value and merger execution make the equity highly speculative. What to watch next: the hearing outcome, the unit offering and the Cortigent merger. This is information only and not investment advice. Futures were muted on Tuesday morning with JPMorgan, Wells Fargo, Goldman Sachs and Citigroup reporting before the bell, and JPMorgan's EPS of USD 5.57 missed a USD 5.90 forecast before the stock recovered. South Korea's Kospi fell 5.5% on memory valuation concerns and China competition, Nasdaq 100 futures were down about 0.5%, and S&P 500 third-quarter earnings are expected to grow 30.6%.

Where Things Stand

Market conditions frame the day: futures were muted as big banks report, the Kospi fell 5.5% and chip and memory stocks were under pressure. ClearOne (NASDAQ:CLRO) is moving with a Nasdaq delisting determination. A pre-market drop on this volume can reverse once regular trading opens, so the balance of evidence favors waiting for confirmation from filings and the open. Direction remains unknown, and the next catalyst is the hearing outcome, the unit offering and the Cortigent merger. Check the underlying filings first, verify the latest filings before acting, and treat the figures as a snapshot.